A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass

Michael S. Avidan, Jerrold H. Levy, Jens Scholz, Elise Delphin, Peter M.J. Rosseel, Michael B. Howie, Irwin Gratz, Charles R. Bush, Nikolaos Skubas, Gabriel S. Aldea, Michael Licina, Laura J. Bonfiglio, Daniel K. Kajdasz, Elizabeth Ott, George J. Despotis

Research output: Contribution to journalArticlepeer-review

108 Scopus citations

Fingerprint

Dive into the research topics of 'A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass'. Together they form a unique fingerprint.

Medicine & Life Sciences